Cardiovascular Therapy: Open Access
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • Cardiovasc Ther 2017, Vol 2(1): 115

High Serum Level of Secreted Frizzled-Related Protein 5 (sfrp5) is Associated with Future Cardiovascular Events

Hongwei Ji, Hailing Li, Jianhui Zhuang, Yang Su, Jing Wen, Jingying Zhang, Dongdong Zhao, Yi Zhang* and YaWei Xu*
Department of Cardiology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China
*Corresponding Author (s) : Yi Zhang MD, PhD, Department of Cardiology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, 301 Middle Yanchang Road, Shanghai 200072, China, Tel: +086-21-66307274, Fax: 086-21-66306381, Email: yizshcn@gmail.com
YaWei Xu MD, PhD, FACC, FESC, Department of Cardiology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, 301 Middle Yanchang Road, Shanghai 200072, China, Tel: +086-21-66307274, Fax: 086-21-66306381, Email: xuyawei@tongji.edu.cn

Received Date: Feb 13, 2017 / Accepted Date: Mar 17, 2017 / Published Date: Mar 25, 2017

Abstract

Objectives: Novel biomarkers to predict future risk of coronary artery disease, especially in the early stage, are warranted. The goal of this study was to determine whether SFRP5, a novel anti-inflammatory adipokine, is associated with future cardiovascular events.
Methods: This is a 4-year follow-up study that included 81 subjects with CAG (+) and 87 subjects with CAG (-). SFRP5 levels was analyzed by ELISA. 2-year and 4-year follow-up were conducted for the occurrence of major adverse cardiac events (MACE), including unstable angina pectoris, ischemic stroke, nonfatal myocardial infarction, revascularization, and cardiovascular death.
Results: In multivariate Cox regression analysis, high SFRP5 significantly predicted patients’ MACE with an HR of 2.174 (95% CI 1.169, 4.041; p=0.014) at 2-year follow-up, and with an HR of 1.974 (95% CI 1.138, 3.426; p=0.016) at 4-year follow-up respectively. The incidence of MACE was significantly increased in the high SFRP5 group for CAG(-) patients ((HR (95%CI) 3.326(1.275, 8.680), p=0.014 for 2-year; HR (95%CI) 2.590(1.122, 5.978), p=0.026) for 4-year), as well as for patients over 65 years (HR(95%CI) 4.931(1.989, 12.222), p<0.001 for 2-year; HR(95%CI) 3.194(1.541, 6.621), p=0.002 for 4-year, respectively).
Conclusion: A high serum concentration of SFRP5 is associated with the occurrence of future CV events,especially in the elderly.

Keywords: SFRP5; Coronaryarterydisease; Cardiovascularevent; Angiography; Hypertension; Inflammation

Citation: Ji H, Li H, Zhuang J, Su Y, Wen J, et al. (2017) High Serum Level of Secreted Frizzled-Related Protein 5 (sfrp5) is Associated with Future Cardiovascular Events. Cardiovasc Ther 2: 115.

Copyright: © 2017 Ji H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top